New-Onset Atrial Fibrillation in Acute Myocardial Infarction Is a Different Phenomenon than Other Pre-Existing Types of That Arrhythmia

Figures

• 

  Figure 1. hsTnI concentration within the first four days of hospitalization. The center represents the median value. The upper and lower quartiles values are displayed with whiskers. p-values on the figure represent the group changes (the Kruskal–Wallis test). The time changes were calculated by the Friedman test and paired samples Wilcoxon test with Bonferroni adjusted (p < 0.001). hsTnI—high sensitivity troponin I; NOAF—group of patients with any newly diagnosed AF that appeared during AMI hospitalization; AF—group of patients with a previously documented diagnosis of AF who additionally had AF during AMI hospitalization; Prior AF—group of patients with a previously documented diagnosis of AF who had not developed AF during AMI hospitalization; Non-AF—group of patients with no evidence of AF during AMI hospitalization and without the prior AF diagnosis.

• 

  Figure 2. CRP concentration within the first four days of hospitalization. The center represents the median value. The upper and lower quartiles values are displayed with whiskers. p-values on the figure represent the group changes (the Kruskal–Wallis test). The time changes were calculated by the Friedman test and paired samples Wilcoxon test with Bonferroni adjusted (p < 0.001). CRP—C-reactive protein; NOAF—group of patients with any newly diagnosed AF that appeared during AMI hospitalization; AF—group of patients with a previously documented diagnosis of AF who additionally had AF during AMI hospitalization; Prior AF—group of patients with a previously documented diagnosis of AF who had not developed AF during AMI hospitalization; Non-AF—group of patients with no evidence of AF during AMI hospitalization and without the prior AF diagnosis.

• 

  Figure 3. Leucocytes within the first four days of hospitalization. The center represents the median value. The upper and lower quartiles values are displayed with whiskers. p-values on the figure represent the group changes (the Kruskal–Wallis test). The time changes were calculated by the Friedman test and paired samples Wilcoxon test with Bonferroni adjusted (p < 0.001). NOAF—group of patients with any newly diagnosed AF that appeared during AMI hospitalization; AF—group of patients with a previously documented diagnosis of AF who additionally had AF during AMI hospitalization; Prior AF—group of patients with a previously documented diagnosis of AF who had not developed AF during AMI hospitalization; Non-AF—group of patients with no evidence of AF during AMI hospitalization and without the prior AF diagnosis.

• 

  Figure 4. Potassium concentration within the first four days of hospitalization. The center represents the median value. The upper and lower quartiles values are displayed with whiskers. p-values on the figure represent the group changes (the Kruskal–Wallis test). The time changes were calculated by the Friedman test and paired samples Wilcoxon test with Bonferroni adjusted (p < 0.004). NOAF—group of patients with any newly diagnosed AF that appeared during AMI hospitalization; AF—group of patients with a previously documented diagnosis of AF who additionally had AF during AMI hospitalization; Prior AF—group of patients with a previously documented diagnosis of AF who had not developed AF during AMI hospitalization; Non-AF—group of patients with no evidence of AF during AMI hospitalization and without the prior AF diagnosis.

• 

  Figure 5. Hemoglobin within the first four days of hospitalization. The center represents the median value. The upper and lower quartiles values are displayed with whiskers. p-values on the figure represent the group changes (the Kruskal–Wallis test). The time changes were calculated by the Friedman test and paired samples Wilcoxon test with Bonferroni adjusted (p < 0.001). NOAF—group of patients with any newly diagnosed AF that appeared during AMI hospitalization; AF—group of patients with a previously documented diagnosis of AF who additionally had AF during AMI hospitalization; Prior AF—group of patients with a previously documented diagnosis of AF who had not developed AF during AMI hospitalization; Non-AF—group of patients with no evidence of AF during AMI hospitalization and without the prior AF diagnosis.